Literature DB >> 24361631

Pediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected children.

Shaffiq M Essajee1, Stephen M Arpadi, Eric J Dziuban, Raul Gonzalez-Montero, Shirin Heidari, David G Jamieson, Scott E Kellerman, Emilia Koumans, Atieno Ojoo, Emilia Rivadeneira, Stephen A Spector, Helena Walkowiak.   

Abstract

Treatment 2.0 is an initiative launched by UNAIDS and WHO in 2011 to catalyze the next phase of treatment scale-up for HIV. The initiative defines strategic activities in 5 key areas, drugs, diagnostics, commodity costs, service delivery and community engagement in an effort to simplify treatment, expand access and maximize program efficiency. For adults, many of these activities have already been turned into treatment policies. The recent WHO recommendation to use a universal first line regimen regardless of gender, pregnancy and TB status is a treatment simplification very much in line with Treatment 2.0. But despite that fact that Treatment 2.0 encompasses all people living with HIV, we have not seen the same evolution in policy development for children. In this paper we discuss how Treatment 2.0 principles can be adapted for the pediatric population. There are several intrinsic challenges. The need for distinct treatment regimens in children of different ages makes it hard to define a one size fits all approach. In addition, the fact that many providers are reluctant to treat children without the advice of specialists can hamper decentralization of service delivery. But at the same time, there are opportunities that can be availed now and in the future to scale up pediatric treatment along the lines of Treatment 2.0. We examine each of the five pillars of Treatment 2.0 from a pediatric perspective and present eight specific action points that would result in simplification of pediatric treatment and scale up of HIV services for children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24361631      PMCID: PMC4682195          DOI: 10.1097/QAD.0000000000000091

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings.

Authors:  Gayle G Sherman; Gwynneth Stevens; Stephanie A Jones; Pamela Horsfield; Wendy S Stevens
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-15       Impact factor: 3.731

Review 2.  Family-centred approaches to the prevention of mother to child transmission of HIV.

Authors:  Theresa S Betancourt; Elaine J Abrams; Ryan McBain; Mary C Smith Fawzi
Journal:  J Int AIDS Soc       Date:  2010-06-23       Impact factor: 5.396

3.  Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.

Authors:  Michael L Rich; Ann C Miller; Peter Niyigena; Molly F Franke; Jean Bosco Niyonzima; Adrienne Socci; Peter C Drobac; Massudi Hakizamungu; Alishya Mayfield; Robert Ruhayisha; Henry Epino; Sara Stulac; Corrado Cancedda; Adolph Karamaga; Saleh Niyonzima; Chase Yarbrough; Julia Fleming; Cheryl Amoroso; Joia Mukherjee; Megan Murray; Paul Farmer; Agnes Binagwaho
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

4.  Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique.

Authors:  Tom Decroo; Barbara Telfer; Marc Biot; Jacob Maïkéré; Sergio Dezembro; Luisa Isabel Cumba; Carla das Dores; Kathryn Chu; Nathan Ford
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

5.  The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.

Authors:  Brenda Waning; Ellen Diedrichsen; Elodie Jambert; Till Bärnighausen; Yun Li; Mieke Pouw; Suerie Moon
Journal:  BMC Pediatr       Date:  2010-10-17       Impact factor: 2.125

6.  Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification.

Authors:  David S Boyle; Dara A Lehman; Lorraine Lillis; Dylan Peterson; Mitra Singhal; Niall Armes; Mathew Parker; Olaf Piepenburg; Julie Overbaugh
Journal:  MBio       Date:  2013-04-02       Impact factor: 7.867

7.  Facilitating HIV testing, care and treatment for orphans and vulnerable children aged five years and younger through community-based early childhood development playcentres in rural Zimbabwe.

Authors:  Diana Patel; Priscilla Matyanga; Tichaona Nyamundaya; Delia Chimedza; Karen Webb; Barbara Engelsmann
Journal:  J Int AIDS Soc       Date:  2012-07-11       Impact factor: 5.396

8.  Laboratory systems and services are critical in global health: time to end the neglect?

Authors:  John N Nkengasong; Peter Nsubuga; Okey Nwanyanwu; Guy-Michel Gershy-Damet; Giorgio Roscigno; Marc Bulterys; Barry Schoub; Kevin M DeCock; Deborah Birx
Journal:  Am J Clin Pathol       Date:  2010-09       Impact factor: 2.493

9.  Linkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa.

Authors:  Nei-Yuan Hsiao; Kathryn Stinson; Landon Myer
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Successful paediatric HIV treatment in rural primary care in Africa.

Authors:  N Janssen; J Ndirangu; M-L Newell; R M Bland
Journal:  Arch Dis Child       Date:  2009-10-29       Impact factor: 3.791

View more
  1 in total

1.  Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.

Authors:  Anna Gamell; Tracy R Glass; Lameck B Luwanda; Herry Mapesi; Leila Samson; Tom Mtoi; Angelo Nyamtema; Lukas Muri; Alex Ntamatungiro; Marcel Tanner; Christoph Hatz; Manuel Battegay; Emilio Letang
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.